ENG | SWE
- About Allenex
- Transplantation
- IR and Press
- Corporate Governance
- Articles of Association
- Board of Directors
- Executive Management
- Remuneration Guidelines
- The Board of Directors’ Work Procedures and Tasks
- Annual General Meeting
- Nomination Committee
- Auditor
- Annual Information to FI
- Affärside, Vision, Strategi, Mål
- Styrelse
- Bolagsledning
- Organisation
- Historik
- Arbeta hos oss
- Olerup SSP
- Absorber
- Distribution och försäljning
- Forskning och utveckling
- Pressmeddelanden
- Finansiella rapporter
- Emissioner och Prospekt
- Presentationer och Analyser
- Kalendarium
- Aktiekurs
- Största Aktieägare
- Insynsregistret
- Prenumerationsservice
- Konvertibellån 2010-2012
- IR kontakt
- Bolagsordning
- Styrelsen
- Bolagsledning
- Ersättningsprinciper
- Styrelsens arbete
- Bolagsstämmor
- Valberedning
- Revisor
- Årlig information till FI
- Diagnostik och Medicinteknik
- Läkemedelsutveckling och Bioteknik
- Contact Us
- VC Investments
Corporate Governance > Auditor
Auditor
The Company’s auditor is Lars Träff, Ernst & Young AB, who was elected by shareholders at the 2008 Annual General Meeting for the period until the 2012 Annual General Meeting.
Annual Reports
2012-02-23
Yer-end report 2011
2012-05-08
Allenex Annual General Meeting 2012
2011-11-16
Interim report January - September 2011
2011-08-25
Interim report January - June 2011
2011-05-31
Interim Report January - March 2011
2012-02-22
17:09:31
0.00%
| 1.63
Volym 10246
Allenex AB
Box 122 83
102 27 Stockholm, Sweden
Visiting address: Franzéngatan 5
Tel: +46 8 50 89 39 00
E-post: info@allenex.se
© 2012 Allenex AB.
All rights reserved.